|
Variable
|
TDF
|
ETV
|
P
|
|---|
|
Patients, n (%)
|
107
|
(45.92)
|
126
|
(54.08)
| |
|
Male sex, n (%)
|
82
|
(76.63)
|
107
|
(84.92)
|
0.08
|
|
Age, M (range)
|
52
|
(25–69)
|
55
|
(26–73)
|
0.31
|
|
CTP class A/B/C, n (%)
| | | | |
0.11
|
|
A
|
105
|
(98.13)
|
122
|
(96.82)
| |
|
B
|
2
|
(1.87)
|
4
|
(3.18)
| |
|
C
|
0
| |
0
| | |
|
HBV DNA, log copies/ml
|
3.7
|
(3.0–4.7)
|
4.1
|
(3.0–5.1)
|
0.07
|
|
HBeAg postive, n (%)
|
76
|
(71.03)
|
88
|
(69.84)
|
0.14
|
|
Cirrhosis, n (%)
|
59
|
(55.14)
|
37
|
(29.36)
|
0.03
|
|
AFP, ng/mL, M (range)
|
97.5
|
(7.8–1210)
|
109
|
(10.3–1210)
|
0.33
|
|
Tumor maximum size, cm, M (range)
|
3.8
|
(2.8–9.7)
|
4.4
|
(2.6–8.5)
| |
|
TBIL, mmol/L, M (range)
|
4.78
|
(2.6–64.7)
|
7.41
|
(3.90–54.30)
|
0.16
|
|
ALT, IU/L, M (range)
|
21
|
(11–41)
|
27
|
(19–57)
|
0.11
|
|
AST, IU/L, M (range)
|
28
|
(19–56)
|
21
|
(20–78)
|
0.41
|
|
ALP, IU/L, M (range)
|
49
|
(45–111)
|
58
|
(51–187)
|
0.09
|
|
ALB, g/L, M (range)
|
3.5
|
(2.3–5.7)
|
4.1
|
(2.5–5.1)
|
0.64
|
|
PLT, 10^9/L, M (range)
|
134.24
|
(79–241)
|
183
|
(99–210)
|
0.21
|
|
PT, s, M (range)
|
11.9
|
(11.3–12.6)
|
12.5
|
(11.7–13.6)
|
0.08
|
|
INR, M (range)
|
1.01
|
(0.77–1.24)
|
0.97
|
(0.81–1.21)
|
0.51
|
- AFP = α-fetoprotein, ALB = albumin, ALP = alkaline phosphatase,ALT = alanine aminotransferase, AST = aspartate aminotransferase, CTP=Child–Trucott–Pugh score, HBV = hepatitis B virus, INR = international normalized ratio, PLT = platelet, PT = prothrombin time, TBIL = total bilirubin
